AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+14.3%/yr
vs +3.1%/yr prior
5Y CAGR
+6.0%/yr
Recent acceleration
Acceleration
+11.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $64.36B | +11.7% |
| 2024 | $57.64B | +58.6% |
| 2023 | $36.34B | -15.7% |
| 2022 | $43.11B | -20.1% |
| 2021 | $53.95B | +12.3% |
| 2020 | $48.02B | +20.7% |
| 2019 | $39.80B | +4.3% |
| 2018 | $38.17B | +9.8% |
| 2017 | $34.76B | +8.1% |
| 2016 | $32.16B | - |